Allopregnanolone belongs to a group of
neuroactive steroid hormones, or
neurosteroids, synthesized and acting within the brain and is as a potent endogenous positive modulator of
GABA(A) receptor complex. Administration of
allopregnanolone protects rats against pentylentetrazol,
bicuculline,
kainic acid, and
picrotoxin-induced
seizures. We investigated serum
allopregnanolone levels in children with active
epilepsy at pubertal Tanner's stage I (n=52). Blood specimens were collected at least 12 h after a seizure (inter-ictal). In a subgroup of patients (n=11), specimens were also collected within 30 min from a seizure attack (post-ictal). Healthy age-matched children (n=18) served as controls. Serum
allopregnanolone was measured by radioimmunoassay using a polyclonal antiserum. The inter-ictal serum
allopregnanolone levels in the epileptic children were not statistically different from those detected in the control group, whereas post-ictal levels were significantly higher than the inter-ictal ones (P=0.0001). In this subgroup of patients
allopregnanolone levels decreased to the basal values during the following 12 h. Serum
allopregnanolone levels may therefore reflect changes in neuronal excitability, and
allopregnanolone appears to be a reliable circulating marker of epileptic
seizures. It is possible that increased post-ictal serum levels of
allopregnanolone may play a role in modulating neuronal excitability and may represent an endogenous mechanism of seizure control.